Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telcagepant + Ibuprofen/Acetaminophen in Migraine
NCT00758836Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of telcagepant in migraine (4 arms), sponsored by Merck & Co. Primary endpoints: Percentage of Participants With Pain Freedom at Two Hours Post-dose at 2 hours, Number of Participants Experiencing Adverse Events Within 48 Hours Post-dose and 1 more. Started Dec 2008; status: completed.
02
Drugs
telcagepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00758836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00758836.